Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Paricalcitol and Calcitriol for Reparative Management of Chronic Allograft Dysfunction and Renocardiac Syndrome in Vitamin D Insufficient Renal Transplant Recipients

NCT01265615 is registered in ClinicalTrials.gov with Ural State Medical University as lead sponsor.

NCT NCT01265615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01265615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Paricalcitol and Calcitriol for Reparative Management of Chronic Allograft Dysfunction and Renocardiac Syndrome in Vitamin D Insufficient Renal Transplant Recipients
Lead sponsor
Ural State Medical University
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2009
Completion date
September 30, 2010
Enrollment
109 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiorenal syndrome, chronic allograft nephropathy